Sort
82,697 grants matching “vaccine development”
Humoral Responses
$851,094Guido Ferrari · Wistar Institute · U19 · FY2016 · AI
KSHV Subunit Vaccine Candidates to Elicit Potent Humoral Immune Reponses against KSHV Infection
$851,034Javier Gordon Ogembo · Beckman Research Institute/City Of Hope · R01 · FY2023 · AI
Blocking granzyme-mediated immune suppression to enhance HIV vaccine efficacy
$851,001Stephen N. Waggoner · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · AI
Defining functional humoral correlates of immunity to guide vaccine design
$850,980Galit Alter · Massachusetts General Hospital · R01 · FY2021 · AI
Enhanced Oral Vaccine Delivery Vehicle
$850,927Sean N Tucker · Vaxart, Inc. · R44 · FY2010 · AI
Design of inhibitors targeted to the CD4 binding site on HIV-1 gp120
$850,888Asim K Debnath · New York Blood Center · R01 · FY2022 · AI
Mechanisms of mucosal protection induced by attenuated SIV
$850,843R. Paul Johnson · Harvard Medical School · P01 · FY2007 · AI
POPULATION SCALE HLA TYPING FOR HOMELAND DEFENSE
$850,816Krishna Jayaraman · Genomics Usa, Inc. · R44 · FY2008 · AI
Vector Biological Studies in Leishmaniasis
$850,811David Sacks · Niaid Extramural Activities · Z01 · FY2007 · AI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS
$850,811David Sacks · Niaid Extramural Activities · Z01 · FY2007 · AI
Integrated genomics research in parasitic tropical diseases
$850,797Joana Carneiro Da Silva · University Of Maryland Baltimore · U19 · FY2018 · AI
Influence of HIV infection on vaginal virome and risk of preterm birth in pregnant South African women
$850,737Heather Beryl Jaspan · Seattle Children'S Hospital · R01 · FY2023 · HD
Development of an mRNA-Based Therapeutic HIV/AIDS Vaccine
$850,670Afamefuna Okoye · Oregon Health & Science University · R01 · FY2020 · AI
Infection-blocking antibody targets for malaria
$850,549Stefan H.i. Kappe · Seattle Biomedical Research Institute · R01 · FY2017 · AI
Infection-blocking antibody targets for malaria
$850,549Stefan H.i. Kappe · Seattle Biomedical Research Institute · R01 · FY2016 · AI
VERMONT IMMUNOBIOL/INFECTIOUS DIS CTR: CORE A: ADMINISTRATIVE/INTELLECTUAL CORE
$850,538Ralph C. Budd · University Of Vermont & St Agric College · P20 · FY2010 · RR
In-depth characterization of myeloid cells in human milk from HIV- and HIV+ donors as potential vehicles of and defenders against vertical transmission of HIV: essential data for targeted therapeutics
$850,491Rebecca Powell · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AI
To Develop and Manufacture an Inactivated SARS-CoV-2 Vaccine Using Blood Pathogen Reduction Technology
$850,444Raymond Goodrich · Colorado State University · N01 · FY2024 · AI
Chromatin infrastructure of the Igh locus and its influence on VH gene usage
$850,441Amy L. Kenter · University Of Illinois At Chicago · R01 · FY2017 · AI
Optimizing glycan shield coverage, germline B cell receptor binding and epitope diversity of V2-apex targeted HIV-1 Env immunogens
$850,346Beatrice H Hahn · University Of Pennsylvania · R37 · FY2023 · AI
Defining the Role of Host Factors in Ebola Virus RNA Synthesis
$850,337Douglas J. Lacount · Washington University · P01 · FY2016 · AI
Perturbation of antigen-specific T cell responses in latent TB/SIV co-infection
$850,330Deepak Kaushal · Tulane University Of Louisiana · R01 · FY2016 · AI
Dissecting Polyclonal Sera to Reveal Correlates of Productive Immune Responses to HIV
$850,304Andrew Barrett Ward · Scripps Research Institute, The · R01 · FY2024 · AI
Basic Research Support for the CCR
$850,265Robert Wiltrout · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
Containing Bioterrorist and Emerging Infectious Diseases
$850,223Ira M Longini · Fred Hutchinson Cancer Research Center · U01 · FY2009 · GM